Atlas Trials

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

Clinical trial NCT00461773 · TERMINATED

Trial details

NCT number
NCT00461773
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-Sensitive Breast CancerBreast Cancer
Start date
2007-03-01
Primary completion
2010-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.